ProLynx Inc is a clinical-stage biopharmaceutical company specializing in the development of novel long-acting therapeutics. We are leveraging our drug delivery platform technology to enhance the delivery, half-life, efficacy, and safety of drugs. ProLynx’s technology enables predictable and controllable half-life extension of drugs – including peptides, proteins and small molecules – using nano, macromolecular and fix supports (SC, IV & IT injectables, implants, and others). This technology improves the pharmacokinetics, pharmacodynamics, and reduced dosing frequency compared to conventional delivery methods.
View Top Employees from ProlynxWebsite | http://www.prolynxinc.com |
Revenue | $1 million |
Employees | 10 (10 on RocketReach) |
Founded | 2009 |
Address | 135 Mississippi St, San Francisco, California 94107, US |
Phone | (415) 552-5306 |
Industry | Biotechnology, Business Services General, Tailored "tunable" pharmacokinetics for peptides, Business Services, Science and Engineering, Proteins Or Small Molecules., Manufacturing |
Web Rank | 18 Million |
Keywords | Prolynx |
Competitors | ArQule, Cellectar Biosciences, Inc., Concortis Biosystems Corp, TetraGenetics Inc. |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Prolynx employee's phone or email?
The Prolynx annual revenue was $1 million in 2024.
Daniel Santi is the President of Prolynx.
10 people are employed at Prolynx.
Prolynx is based in San Francisco, California.
The NAICS codes for Prolynx are [32541, 3254, 325, 32].
The SIC codes for Prolynx are [28, 283].